{
  "ticker": "LLY",
  "timestamp": "2025-12-01T09:05:49.652865",
  "analysis_date": "2025-02-24",
  "historical_mode": true,
  "summary": {
    "recommendations": {
      "technical": "BUY",
      "news": "HOLD",
      "fundamental": "HOLD",
      "macro": "HOLD"
    },
    "valid_recommendations": {
      "technical": "BUY",
      "news": "HOLD",
      "fundamental": "HOLD",
      "macro": "HOLD"
    },
    "confidence_levels": {
      "technical": "Medium",
      "news": "Medium",
      "fundamental": "Low",
      "macro": "Low"
    },
    "bull_signal_count": 30,
    "bear_signal_count": 12,
    "bull_rec_count": 1,
    "bear_rec_count": 0,
    "hold_rec_count": 3,
    "undetermined_count": 0,
    "analyst_count": 4,
    "valid_analyst_count": 4,
    "net_sentiment": "BULLISH"
  },
  "analyst_summaries": {
    "technical": "TECHNICAL: Uptrend confirmed, RSI 14 \u2192 BUY (Medium)",
    "news": "NEWS: Bullish sentiment (33 articles) \u2192 HOLD (Medium)",
    "fundamental": "FUNDAMENTAL: Mixed fundamentals \u2192 HOLD (Low)",
    "macro": "MACRO: Mixed macro \u2192 HOLD (Low)"
  },
  "full_analyst_reports": {
    "technical": "[TECHNICAL] *** HISTORICAL MODE: Analyzing as of 2025-02-24 ***\n\n======================================================================\nTECHNICAL ANALYSIS: LLY\nAnalysis Period: 7 days\n*** HISTORICAL MODE: As of 2025-02-24 ***\nTimestamp: 2025-12-01 09:04:21\n======================================================================\n\n[TECHNICAL] Fetching 7-day price data for LLY...\n[TECHNICAL] \u2713 Historical: 48 days ending 2025-02-24\n[TECHNICAL]   Date range: 2024-12-12 to 2025-02-24\n[TECHNICAL] \u2713 Retrieved 48 days of data\n[TECHNICAL] Calculating technical indicators...\n[TECHNICAL] \u2713 Indicators calculated\n[TECHNICAL] Identifying support/resistance levels...\n[TECHNICAL] \u2713 Support: $772.94, Resistance: $889.31\n[TECHNICAL] Formatting technical summary...\n[TECHNICAL] Generating analysis with gpt-4o-mini...\n[TECHNICAL] \u274c LLM error: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}\n[TECHNICAL] Creating fallback analysis...\n\n[TECHNICAL] \u2713 Analysis complete in 18.79s\n======================================================================\n\n## Technical Analysis\n*Generated using fallback analysis (LLM unavailable)*\n\n\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2025-02-24 \u26a0\ufe0f**\nAll data below is historical, ending on 2025-02-24.\nDo NOT reference any price movements or events after this date.\n\n# Technical Analysis Data for LLY\n\n**Analysis Period:** 7 days (Data: 48 days available)\n**Date:** 2025-02-24\n\n## Price Action\n- **Current Price:** $876.38\n- **Period Change:** +1.27%\n- **Day's Range:** $865.07 - $888.03\n- **Volume:** 3,017,100\n- **Volume Assessment:** Normal levels\n\n## Momentum Indicators\n- **RSI(14):** 73.6 \u2192 **OVERBOUGHT** (Potential pullback) \u26a0\ufe0f\n- **MACD:** 22.978 | Signal: 21.910 | Histogram: 1.068\n  \u2192 Bullish momentum \u2713\n- **Stochastic:** %K=85.5, %D=82.2\n  \u2192 Overbought territory\n\n## Moving Average Analysis\n- **SMA_5:** $865.53 (Above \u2713)\n- **EMA_10:** $859.37 (Above \u2713)\n- **SMA_20:** $841.89 (Above \u2713)\n\n**Trend:** Strong uptrend (price above all MAs) \u2713\n\n## Volatility & Range\n- **Bollinger Bands:** $784.61 < $876.38 < $899.16\n  \u2192 Middle range (80% position)\n- **ATR:** $22.90 (2.61% of price)\n  \u2192 Normal volatility\n\n## Support & Resistance\n- **Key Resistance:** $889.31\n- **Secondary Resistance:** $888.03\n- **Key Support:** $772.94\n- **Secondary Support:** $793.08\n\n- **Distance to Resistance:** +1.5%\n- **Distance to Support:** +13.4%\n\n## Potential Trade Setup\n- **Setup Type:** LONG\n- **Entry:** $876.38\n- **Stop Loss:** $842.03 (Risk: $34.35)\n- **Target:** $889.31 (Reward: $12.93)\n- **Risk/Reward Ratio:** 0.38:1\n  \u2192 Poor risk/reward \u26a0\ufe0f\n\n\n---\n\n## Automated Assessment\n\n**Signals Detected:** 2 bullish, 0 bearish\n**Reasoning:** Multiple bullish signals: Strong uptrend, Price above MAs\n\nRECOMMENDATION: BUY - Confidence: Medium\n\n",
    "news": "[NEWS] *** HISTORICAL MODE: Analyzing as of 2025-02-24 ***\n\n======================================================================\nNEWS & SENTIMENT ANALYSIS: LLY\n*** HISTORICAL MODE: As of 2025-02-24 ***\nPeriod: Last 7 days | Sources: ['yahoo', 'finnhub']\nTimestamp: 2025-12-01 09:04:42\n======================================================================\n\n[NEWS] \ud83d\udd27 Fetching Yahoo Finance news...\n[NEWS] \u26a0\ufe0f Yahoo Finance has limited historical news support\n[NEWS] \u2713 Yahoo Finance: 0 articles\n[NEWS] \ud83d\udd27 Fetching Finnhub news...\n[NEWS] Finnhub: Fetching news from 2025-02-17 to 2025-02-24\n[NEWS] \u2713 Finnhub: 33 articles\n[NEWS] \ud83d\udccb Enhancing 33 articles with background context\n[NEWS] \u26a0\ufe0f Date 2025-02-24 is past LLM knowledge cutoff (2024-01-01)\n[NEWS] \u26a0\ufe0f Skipping LLM context to prevent hallucination\n[NEWS] Analyzing with gpt-4o-mini...\n[NEWS] \u2713 Analysis complete (2066 chars)\n\n[NEWS] \u2713 Analysis complete in 19.58s\n======================================================================\n\n# News & Sentiment Analysis: LLY\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2025-02-24 \u26a0\ufe0f**\n**Analysis Period:** Last 7 Days\n**Date:** 2025-12-01 09:04\n\n======================================================================\n\n## Yahoo Finance News (7 Days before 2025-02-24)\n\nNo news found in the specified period\n(Historical mode: news before 2025-02-24)\n## Finnhub News (2025-02-17 to 2025-02-24)\n\n**Found 33 articles**\n\n1. **Hartford Healthcare Fund Q4 2024 Commentary**\n   - Source: SeekingAlpha\n   - Published: today\n   - The Hartford Healthcare Fund (I share) underperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here....\n\n2. **Drug compounders sue US FDA over removal of Wegovy, Ozempic from shortage list**\n   - Source: Finnhub\n   - Published: today\n   - Drug compounders sued the U.S. Foodand Drug Administration on Monday over its decision last week toremove Novo Nordisk's weight-loss and diabetestreat...\n\n3. **Pfizer Hires Top FDA Official Just Weeks After She Leaves Agency**\n   - Source: MarketWatch\n   - Published: today\n   - Pfizer Hires Top FDA Official Just Weeks After She Leaves Agency...\n\n4. **Hartford Growth Opportunities Fund Q4 2024 Commentary**\n   - Source: SeekingAlpha\n   - Published: today\n   - The Hartford Growth Opportunities Fund (I shares) outperformed the Russell 3000 Growth Index during the quarter. Read more here....\n\n5. **Columbia Large Cap Growth Fund Q4 2024 Commentary**\n   - Source: SeekingAlpha\n   - Published: today\n   - Columbia Large Cap Growth Fund Institutional Share Class Shares returned 5.71% for Q4 2024. Click here to read the full commentary. ...\n\n6. **Hartford Core Equity Fund Q4 2024 Commentary**\n   - Source: SeekingAlpha\n   - Published: today\n   - Hartford Core Equity Fund (I Share) outperformed the S&P 500 Index during the quarter. Read more here....\n\n7. **Hims & Hers Declines - How The GLP-1 Market Shift Affects Growth**\n   - Source: SeekingAlpha\n   - Published: today\n   - Hims & Hers plans to launch a generic version of liraglutide, but its efficacy is significantly lower than semaglutide. See why HIMS stock is a Hold....\n\n8. **Why AbbVie Remains A Strong Buy For Long-Term Investors**\n   - Source: SeekingAlpha\n   - Published: today\n   - Discover why AbbVie stands out for long-term investors with strong growth in Skyrizi & Qulipta sales....\n\n\n======================================================================\n\n## News & Sentiment Summary\nAs of February 24, 2025, there is a notable lack of significant news directly impacting Eli Lilly (LLY), with limited coverage in the past week. The overall sentiment in the healthcare sector appears mixed, with discussions surrounding drug market dynamics and competitive actions from other pharmaceutical companies.\n\n## Key Headlines\n1. **Drug Compounders Sue US FDA**  \n   - **Impact Assessment:** Medium  \n   - This lawsuit regarding FDA's removal of certain drugs from the shortage list could impact market perceptions of drug availability and competition, indirectly affecting companies like LLY that operate within similar therapeutic areas.\n\n2. **Hims & Hers Declines - Impact of GLP-1 Market Shift**  \n   - **Impact Assessment:** Medium  \n   - The commentary on Hims & Hers' struggles in the GLP-1 market, which includes products similar to LLY's offerings, indicates a changing market landscape that may affect future sales and competition for LLY.\n\n3. **Pfizer Hires Top FDA Official**  \n   - **Impact Assessment:** Low  \n   - Although this news is significant for Pfizer, it does not directly impact LLY but reflects ongoing changes in regulatory relationships within the industry.\n\n## Sentiment Assessment\n- **Overall Sentiment:** Neutral\n- **Sentiment Trend:** Stable\n- **News Volume:** Low\n\n## Catalysts Identified\n**Bullish Catalysts:** None identified in the recent news cycle.\n**Bearish Catalysts:** \n- Legal challenges affecting drug availability (FDA lawsuit).\n- Competitive pressures highlighted by market shifts affecting similar products (Hims & Hers decline).\n\n**Upcoming Events:** None noted in the recent news.\n\n## Trading Implications\nGiven the lack of direct positive news and the presence of competitive threats, the current environment suggests caution. With the absence of significant catalysts that could drive LLY's stock price upward, coupled with potential headwinds from competitors, it may be prudent to hold existing positions rather than initiate new ones.\n\nRECOMMENDATION: HOLD - Confidence: Medium\n",
    "fundamental": "[FUNDAMENTALS] *** HISTORICAL MODE: Analyzing as of 2025-02-24 ***\n\n======================================================================\nFUNDAMENTAL ANALYSIS: LLY\n*** HISTORICAL MODE: As of 2025-02-24 ***\nTimestamp: 2025-12-01 09:05:05\n======================================================================\n\n[FUNDAMENTALS] Fetching comprehensive data for LLY...\n[FUNDAMENTALS] \u2713 Comprehensive data retrieved\n[FUNDAMENTALS] Calculating historical metrics for 2025-02-24...\n[FUNDAMENTALS] \u2713 Historical metrics calculated: 4\n[FUNDAMENTALS]   - Price: $876.38\n[FUNDAMENTALS]   - P/E: 145.79\n[FUNDAMENTALS]   - P/B: 55.27\n[FUNDAMENTALS]   - Current Ratio: 1.15\n[FUNDAMENTALS] Analyzing earnings history...\n[FUNDAMENTALS] Filtering earnings to before 2025-02-24\n[FUNDAMENTALS] \u2713 Earnings analysis complete (3/4 beats)\n[FUNDAMENTALS] Fetching SEC 10-K filing data...\n[FUNDAMENTALS] Generating analysis with gpt-4o-mini...\n[FUNDAMENTALS] \u274c LLM error: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}\n\n[FUNDAMENTALS] \u2713 Analysis complete in 19.85s\n======================================================================\n\n## Fundamental Analysis Summary\n*Generated using fallback analysis (LLM unavailable)*\n\n\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2025-02-24 \u26a0\ufe0f**\nMetrics marked \"N/A\" could not be calculated historically - ignore them in your analysis.\nOnly analyze metrics with actual values.\n\n# Fundamental Data for LLY\n\n## Company Information\n- **Name:** Eli Lilly and Company\n- **Sector:** Healthcare\n- **Industry:** Drug Manufacturers - General\n\n## Current Price\n- **Price:** $876.38\n- **52-Week High:** $1111.99\n- **52-Week Low:** $623.78\n\n## Valuation Metrics\n- **Market Cap:** $964.11B\n- **Enterprise Value:** $995.68B\n- **Trailing P/E:** 145.79\n- **Forward P/E:** N/A (historical - forward-looking)\n- **PEG Ratio:** N/A (historical)\n- **Price/Book:** 55.27\n- **Price/Sales:** 16.23\n- **EV/Revenue:** 16.76\n- **EV/EBITDA:** 34.66\n\n## Growth Metrics\n- **Revenue Growth:** 53.9%\n- **Earnings Growth:** 480.4%\n- **Quarterly Revenue Growth:** N/A\n- **Quarterly Earnings Growth:** N/A\n\n## Profitability\n- **Profit Margin:** 31.0%\n- **Operating Margin:** 48.3%\n- **Gross Margin:** 83.0%\n- **ROE:** 96.5%\n- **ROA:** 17.6%\n\n## Financial Health\n- **Current Ratio:** 1.15\n- **Quick Ratio:** 0.72\n- **Debt/Equity:** 178.52\n- **Total Cash:** $9.91B\n- **Total Debt:** $42.58B\n- **Free Cash Flow:** $1.40B\n\n## Analyst Opinions\n- **Recommendation:** BUY\n- **Number of Analysts:** 27\n- **Target (Mean):** $1024.00\n- **Target (High):** $1500.00\n- **Target (Low):** $770.00\n- **Implied Upside:** -4.8%\n\n## Earnings History (Last 4 Quarters)\n- Unknown: Actual $5.32 vs Est $5.07 (+5.0%) \u2713 Beat\n- Unknown: Actual $3.34 vs Est $3.54 (-5.7%) \u2717 Miss\n- Unknown: Actual $6.31 vs Est $5.59 (+12.9%) \u2713 Beat\n- Unknown: Actual $7.02 vs Est $5.89 (+19.2%) \u2713 Beat\n\n**Summary:** Beat Rate: 75%, Trend: Declining, Quality: Strong\n\n\n\nRECOMMENDATION: HOLD - Confidence: Low\n\n",
    "macro": "[MACRO] *** HISTORICAL MODE: Analyzing as of 2025-02-24 ***\n\n======================================================================\nMACRO ECONOMIC ANALYSIS\nPeriod: 7 days | Sector: All\n*** HISTORICAL MODE: As of 2025-02-24 ***\nTimestamp: 2025-12-01 09:05:27\n======================================================================\n\n[MACRO] Starting iterative analysis...\n[MACRO] Iteration 1/10\n[MACRO] \ud83d\udd27 Executing: get_market_indicators\n[MACRO] \ud83d\udd27 Tool: get_market_indicators (days=7)\n[MACRO] \u2713 Fetched 6/6 indicators\n[MACRO] \ud83d\udd27 Executing: get_sector_performance\n[MACRO] \ud83d\udd27 Tool: get_sector_performance (days=7)\n[MACRO] \u2713 Analyzed 9/9 sectors\n[MACRO] \ud83d\udd27 Executing: get_economic_indicators\n[MACRO] \ud83d\udd27 Tool: get_economic_indicators (days=7)\n[MACRO] \u2713 Economic indicators retrieved\n[MACRO] \ud83d\udd27 Executing: get_market_breadth\n[MACRO] \ud83d\udd27 Tool: get_market_breadth (days=7)\n[MACRO] \u2713 Breadth analysis complete\n[MACRO] Iteration 2/10\n[MACRO] \u274c Error in iterative analysis: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}\n\n[MACRO] \u2713 Complete in 21.95s\n======================================================================\n\n# Macro Analysis (Partial)\n*Analysis Period: 7 days*\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2025-02-24**\n*Successful Tools: 4, Failed: 0*\n\nRaw data gathered successfully:\n\nTools executed: get_market_indicators, get_sector_performance, get_economic_indicators, get_market_breadth\n\nRECOMMENDATION: NEUTRAL - Confidence: Low (Partial data)\n\n"
  },
  "bull_evidence": [
    {
      "source": "technical",
      "signal": "\u2192 Bullish momentum \u2713",
      "strength": 2,
      "keywords_matched": 2
    },
    {
      "source": "technical",
      "signal": "**Reasoning:** Multiple bullish signals: Strong uptrend, Price above MAs",
      "strength": 2,
      "keywords_matched": 2
    },
    {
      "source": "technical",
      "signal": "[TECHNICAL] \u2713 Support: $772",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "## Momentum Indicators",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "**Trend:** Strong uptrend (price above all MAs) \u2713",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Key Support:** $772",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Secondary Support:** $793",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Distance to Support:** +13",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "RECOMMENDATION: BUY - Confidence: Medium",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "- The Hartford Growth Opportunities Fund (I shares) outperformed the Russell 3000 Growth Index during the quarter",
      "strength": 2,
      "keywords_matched": 2
    },
    {
      "source": "news",
      "signal": "**Why AbbVie Remains A Strong Buy For Long-Term Investors**",
      "strength": 2,
      "keywords_matched": 2
    },
    {
      "source": "news",
      "signal": "- Discover why AbbVie stands out for long-term investors with strong growth in Skyrizi & Qulipta sales",
      "strength": 2,
      "keywords_matched": 2
    },
    {
      "source": "news",
      "signal": "[NEWS] \u26a0\ufe0f Yahoo Finance has limited historical news support",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Hartford Growth Opportunities Fund Q4 2024 Commentary**",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Columbia Large Cap Growth Fund Q4 2024 Commentary**",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "- Columbia Large Cap Growth Fund Institutional Share Class Shares returned 5",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "- Hartford Core Equity Fund (I Share) outperformed the S&P 500 Index during the quarter",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Bullish Catalysts:** None identified in the recent news cycle",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "Given the lack of direct positive news and the presence of competitive threats, the current environment suggests caution",
      "strength": 1,
      "keywords_matched": 1
    }
  ],
  "bear_evidence": [
    {
      "source": "technical",
      "signal": "94, Resistance: $889",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "6 \u2192 **OVERBOUGHT** (Potential pullback) \u26a0\ufe0f",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "\u2192 Overbought territory",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Key Resistance:** $889",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Secondary Resistance:** $888",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Distance to Resistance:** +1",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Risk/Reward Ratio:** 0",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "\u2192 Poor risk/reward \u26a0\ufe0f",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "- The Hartford Healthcare Fund (I share) underperformed the S&P Composite 1500 Health Care Index during the quarter",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Hims & Hers Declines - Impact of GLP-1 Market Shift**",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Bearish Catalysts:**",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "- Competitive pressures highlighted by market shifts affecting similar products (Hims & Hers decline)",
      "strength": 1,
      "keywords_matched": 1
    }
  ],
  "key_conflicts": [
    {
      "type": "recommendation_conflict",
      "severity": "MINOR",
      "analysts": [
        "news",
        "technical"
      ],
      "positions": {
        "news": "HOLD",
        "technical": "BUY"
      },
      "description": "news says HOLD while technical says BUY"
    },
    {
      "type": "recommendation_conflict",
      "severity": "MINOR",
      "analysts": [
        "fundamental",
        "technical"
      ],
      "positions": {
        "fundamental": "HOLD",
        "technical": "BUY"
      },
      "description": "fundamental says HOLD while technical says BUY"
    },
    {
      "type": "recommendation_conflict",
      "severity": "MINOR",
      "analysts": [
        "macro",
        "technical"
      ],
      "positions": {
        "macro": "HOLD",
        "technical": "BUY"
      },
      "description": "macro says HOLD while technical says BUY"
    }
  ],
  "consensus_points": [
    {
      "type": "strong_consensus",
      "recommendation": "HOLD",
      "count": 3,
      "description": "Strong consensus: 3/4 analysts say HOLD"
    }
  ],
  "research_priorities": [
    {
      "priority": "URGENT",
      "focus": "time_sensitive_event",
      "description": "Upcoming catalyst detected",
      "signal": "[FUNDAMENTALS] \u2713 Earnings analysis complete (3/4 beats)",
      "source": "fundamental",
      "action": "Research before event occurs"
    }
  ],
  "analyst_reports_summary": {
    "technical": {
      "recommendation": "BUY",
      "confidence": "Medium",
      "report_length": 3043,
      "has_data": true,
      "completed_successfully": true
    },
    "news": {
      "recommendation": "HOLD",
      "confidence": "Medium",
      "report_length": 5462,
      "has_data": true,
      "completed_successfully": true
    },
    "fundamental": {
      "recommendation": "HOLD",
      "confidence": "Low",
      "report_length": 3234,
      "has_data": true,
      "completed_successfully": true
    },
    "macro": {
      "recommendation": "HOLD",
      "confidence": "Low",
      "report_length": 1737,
      "has_data": true,
      "completed_successfully": true
    }
  },
  "data_quality": {
    "status": "COMPLETE",
    "total_analysts": 4,
    "valid_analysts": 4,
    "failed_analysts": 0,
    "failed_list": [],
    "note": null
  },
  "llm_synthesis": "Synthesis error: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}",
  "synthesis_direction": "UNDETERMINED",
  "synthesis_confidence": "N/A"
}